"One of the biggest findings uncovered by FreshLeaf's Q3 2019 report—which is the most comprehensive analysis of the cannabis industry to date—is that the number of new products available to Australian consumers has skyrocketed, growing by more than 40% in just 6 months.
Based on these trends, FreshLeaf is now predicting that the number of SAS-B approvals will reach a total of 28,301 by the end of 2019, representing more than 1,000% growth on the previous year."
- Forums
- ASX - By Stock
- RGT
- pot stock
pot stock, page-13
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RGT (ASX) to my watchlist
|
|||||
Last
30.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.00M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3300 | 31.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
30.0¢ | 313 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3300 | 0.310 |
2 | 3844 | 0.290 |
2 | 20000 | 0.270 |
1 | 4000 | 0.250 |
1 | 17426 | 0.205 |
Price($) | Vol. | No. |
---|---|---|
0.300 | 313 | 1 |
0.305 | 45198 | 3 |
0.315 | 2825 | 2 |
0.340 | 2115 | 2 |
0.370 | 1056 | 1 |
Last trade - 16.16pm 12/07/2024 (20 minute delay) ? |
Featured News
SKS
SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
RGT (ASX) Chart |
Day chart unavailable